Back to Search
Start Over
Oxidation of LDL and extent of peripheral atherosclerosis.
- Source :
-
Free radical research [Free Radic Res] 1999 Aug; Vol. 31 (2), pp. 129-39. - Publication Year :
- 1999
-
Abstract
- Evidence has accumulated for oxidative modification of low-density lipoproteins (LDL) to play an important role in the atherogenic process. Therefore, we investigated the relation between susceptibility of LDL to oxidation and risk of peripheral atherosclerosis among 249 men between 45 and 80 years of age. The ankle-arm index was calculated for both legs as the ratio of systolic blood pressure in the leg divided by the arm systolic blood pressure. The lowest of both ankle-arm indices was used to categorize subjects. Thirty-nine men with an ankle-arm index < 1.00 (20% cut-off point of distribution) were classified as subjects with peripheral atherosclerosis. Subjects with peripheral atherosclerosis reported more often the use of a special diet and the use of antihypertensive medication, aspirin and coumarin derivatives. No significant differences in total, LDL and HDL cholesterol and triglycerides were present between groups. Resistance time and maximum rate of oxidation were measured ex vivo using copper-induced LDL oxidation. Subjects with peripheral atherosclerosis had a significantly lower resistance time, whereas the maximum rate of oxidation tended to be increased in subjects with peripheral atherosclerosis. Odds ratios (ORs, and 95% confidence interval) for the successive tertiles of resistance time were 1.00 (reference), 0.37 (0.15-0.89) and 0.37 (0.16-0.86) (p(trend) < 0.01). ORs for the successive tertiles of maximum rate of oxidation were 1.00 (reference), 1.34 (0.47-3.82) and 1.50 (0.55-4.15). This inverse association was borderline significant (p(trend) = 0.07). These results support an association between LDL oxidation and the development of peripheral atherosclerosis.
- Subjects :
- Aged
Aged, 80 and over
Anticoagulants therapeutic use
Antihypertensive Agents therapeutic use
Arteriosclerosis therapy
Aspirin therapeutic use
Cholesterol, Dietary administration & dosage
Coumarins therapeutic use
Diet, Fat-Restricted
Humans
Male
Middle Aged
Odds Ratio
Risk Factors
Arteriosclerosis blood
Lipid Peroxidation
Lipoproteins, LDL metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1071-5762
- Volume :
- 31
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Free radical research
- Publication Type :
- Academic Journal
- Accession number :
- 10490242
- Full Text :
- https://doi.org/10.1080/10715769900301641